Laboratory diagnosis of influenza virus infection

Pathology

Volumn 34, Issue 2, 2002, Pages 115-125

  Playford, E Geoffrey ^a   Dwyer, Dominic E ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Diagnosis; Diagnostic techniques and procedures; Influenza; Laboratory techniques and procedures; Surveillance

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANTIGEN DETECTION; ARTICLE; AUSTRALIA; COMPLEMENT FIXATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HUMAN; INFLUENZA; INFLUENZA VIRUS; LABORATORY DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS ISOLATION;

EID: 0036226638     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130201201117909     Document Type: Article

References (74)

1. Orthomyxoviridae: The viruses and their replication
2. Human influenza
3. Antibody-mediated immunity
4. Cell-mediated immune response to influenza virus
5. Orthomyxoviruses
6. Predictions for future human influenza pandemics
7. Laboratory diagnosis of influenza
8. The 1976 influenza epidemic in Melbourne
9. Isolation of viruses from nasopharyngeal secretions. Comparison of aspiration and swabbing as means of sample collection
10. Performance of virus isolation and Directogen Flu A to detect influenza A virus in experimental human infection
11. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods
12. Prospective comparative study of culture specimens and methods in diagnosing influenza in adults
13. Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza
14. Use of PCT-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus
15. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996
16. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples
17. Evaluation of R-Mix FreshCells in shell vials for detection of respiratory viruses
18. Mink lung cells and mixed mink lung and A549 cells for rapid detection of influenza virus and other respiratory viruses
19. Comparison of hemagglutination and hemabsorption tests for influenza detection
20. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies
21. Rapid diagnosis of influenza A and B by 24-h fluorescent focus assay
22. Indirect immunofluorescence assay for rapid diagnosis of influenza virus
23. Successful use of shell vial centrifugation and 16 to 18-hour immunofluorescent staining for the detection of influenza A and B in clinical specimens
24. Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies
25. Laboratory diagnosis of respiratory virus infections in 24 hours by utilizing shell vial cultures
26. Diagnosis of respiratory tract viruses in 24h by immunofluorescent staining of shell vial cultures containing Madin-Darby canine kidney (MDCK) cells
27. Comparison of Directogen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus
28. Evaluation of a rapid enzyme immunoassay for detection of influenza A virus
29. Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children
30. Comparison of rapid detection methods for influenza A virus and their value in health-care management of institutionalized geriatric patients
31. Prospective application of reverse transcription polymerase chain reaction for diagnosing influenza infections in respiratory samples from a Children’s Hospital
32. Use of fluorescent-antibody staining of cytocentrifuge-prepared smears in combination with cell culture for direct detection of respiratory viruses
33. Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluorescence and membrane enzyme-linked immunosorbent assay
34. Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens
35. Comparison of rapid immunofluorescence procedure with TestPack RSV and Directogen FLU-A for diagnosis of respiratory syncytial virus and influenza A virus
36. Microwave-accelerated direct immunofluorescent staining for respiratory syncytial virus and influenza A virus
37. A nylon membrane immunoassay for rapid diagnosis of influenza A infection
38. Sensitive immunoassay for the rapid diagnosis of influenza A virus infections in clinical specimens
39. Rapid diagnosis of influenza infection of NP antigen using an immunoscapture ELISA test
40. Rapid viral diagnosis of acute respiratory infections: Comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions
41. Influenza virus
42. Application of Directogen FLU-A for the detection of influenza A virus in human and nonhuman specimens
43. Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR
44. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: Comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA)
45. Treat or test first? Decision analysis of empirical antiviral treatment of influenza versus treatment based on rapid test results
46. Typing and subtyping of influenza viruses in clinical samples by PCR
47. Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus
48. Comparison of RT-PCR with other diagnostic assays for rapid detection of influenza viruses
49. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hezplex)
50. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses
51. Rapid identifcation of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study
52. Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses
53. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR
54. Rapid virological surveillance of community influenza infection in general practice
55. Isotype-specific enzyme immunoassay for influenza antibody with monoclonal antibodies to human immunoglobulins
56. Influenza virus serology-acomparative study
57. Diagnosis of influenza A virus infections by detection of specific immunoglobulins M, A, and G in serum
58. Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients
59. Effect of rapid influenza diagnosis on management of influenza A infections
60. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients
61. Monoclonal antibodies for rapid strain-specific identification of influenza virus isolates
62. Characterization and evaluation of monoclonal antibodies developed for typing influenza A and B viruses
63. Evaluation of monoclonal antibodies for subtyping of currently circulating human type A inflenza viruses
64. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay
65. Typing and subtyping using DNA microarrays and multiplex reverse transcriptase PCR
66. Prevention and treatment of influenza
67. Influenza virus neuraminidase inhibitors
68. Resistance of influenza viruses to neuraminidase inhibitors - A review
69. Annual report of the National Influenza Surveillance Scheme, 1999